论文信息 - Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82–104 - 字舞流文

Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82–104

R. Montironi | G. Paner | Gladell P. Paner

[1] S. Daneshmand,et al. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. , 2020, European urology focus.

[2] J. Witjes,et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. , 2020, European urology.

[3] B. Delahunt,et al. Dataset for the reporting of carcinoma of the bladder—cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR) , 2020, Virchows Archiv.

[4] M. Galsky,et al. What Is the Significance of Variant Histology in Urothelial Carcinoma? , 2020, European urology focus.

[5] M. Babjuk,et al. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. , 2019, European urology.

[6] J. Pow-Sang,et al. Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice. , 2016, Urology.